Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Precision Therapeutics Inc (AIPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,681
  • Shares Outstanding, K 14,090
  • Annual Sales, $ 650 K
  • Annual Income, $ -7,750 K
  • 36-Month Beta 1.21
  • Price/Sales 17.66
  • Price/Cash Flow N/A
  • Price/Book 3.64
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.97
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/14/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.80 +1.25%
on 10/23/18
0.96 -16.06%
on 11/14/18
-0.05 (-5.81%)
since 10/19/18
3-Month
0.80 +1.25%
on 10/23/18
1.24 -34.68%
on 08/31/18
-0.35 (-30.17%)
since 08/20/18
52-Week
0.80 +1.25%
on 10/23/18
1.58 -48.73%
on 07/13/18
-0.60 (-42.76%)
since 11/20/17

Most Recent Stories

More News
Precision Therapeutics Reports Third Quarter 2018 Financial Results

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today financial results...

AIPT : 0.81 (-10.00%)
Helomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian Cancer

Helomics will utilize whole genome and outcome data from the U.K. 100,000 Genomes Project to advance its artificial intelligence-based platform for ovarian cancer.

AIPT : 0.81 (-10.00%)
Precision Therapeutics to Hold Business Update Conference Call on November 14, 2018

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that management...

AIPT : 0.81 (-10.00%)
Precision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its Mutation

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that it has...

AIPT : 0.81 (-10.00%)
Precision Therapeutics' CEO Talks with Uptick Newswire's Stock Day Podcast About Exciting New Breakthroughs in Tumor Treatment and What's on the Horizon

Precision Therapeutics (Nasdaq: AIPT) (The "Company") is a company applying artificial intelligence to personalized medicine and drug discovery. Their CEO, Dr. Carl Schwartz, and Richard Gabriel, a consultant...

AIPT : 0.81 (-10.00%)
Precision Therapeutics Continues to Build World Class Scientific Advisory Board with Appointment of Hector J. Gomez, MD, PhD

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has appointed Dr. Hector J....

AIPT : 0.81 (-10.00%)
Precision Therapeutics Secures First STREAMWAY System Sale in Europe

MINNEAPOLIS, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company") is pleased to announce it has secured its first European sale of the STREAMWAY...

AIPT : 0.81 (-10.00%)
SKLN : 1.21 (-11.03%)
Dr. Bob Murphy, Head of Computational Biology at Carnegie Mellon University, Joins Precision Therapeutics' Scientific Advisory Board

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has appointed Dr. Robert Murphy...

AIPT : 0.81 (-10.00%)
Precision Therapeutics Bolsters Scientific Advisory Board with the Appointment of Dr. Paul Kornblith

Precision Therapeutics Inc. (NASDAQ: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has bolstered its Scientific...

AIPT : 0.81 (-10.00%)
Precision Therapeutics Appoints Dr. Amelia Warner to Scientific Advisory Board

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that...

AIPT : 0.81 (-10.00%)
MRK : 74.78 (-2.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade AIPT with:

Business Summary

Precision Therapeutics Inc. operating business areas includes development of a healthcare CRO which provides personalized medicine solutions for clients in the pharmaceutical, diagnostic and biotech industries as well as production of the FDA-approved STREAMWAY(R) System for automated, direct-to-drain...

See More

Key Turning Points

2nd Resistance Point 0.92
1st Resistance Point 0.86
Last Price 0.81
1st Support Level 0.78
2nd Support Level 0.76

See More

52-Week High 1.58
Fibonacci 61.8% 1.28
Fibonacci 50% 1.19
Fibonacci 38.2% 1.10
Last Price 0.81
52-Week Low 0.80

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar